IL15 and B-cell chronic lymphocytic leukemia: We found that this construct was able to direct IL15 activity to the NK subpopulation, potentiate NK cell functionality, and restore NK-mediated cytotoxicity in CLL PBMCs, suggesting its potential application as an agent for sustaining the anti-tumoral activity of NK cells in CLL and promoting NK-cell-based immunotherapies.